These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21450450)

  • 1. How many HIV infections are prevented by Vancouver Canada's supervised injection facility?
    Pinkerton SD
    Int J Drug Policy; 2011 May; 22(3):179-83. PubMed ID: 21450450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Vancouver Canada's supervised injection facility cost-saving?
    Pinkerton SD
    Addiction; 2010 Aug; 105(8):1429-36. PubMed ID: 20653622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
    Andresen MA; Boyd N
    Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating national-level syringe availability to injecting drug users and injection coverage: Switzerland, 1996-2006.
    Arnaud S; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2011 May; 22(3):226-32. PubMed ID: 21600753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panel: emerging issues in Canada's drug policy--implications for HIV prevention and health promotion for people who use drugs.
    Strike C; Elliott R; Nolin C
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):93-8. PubMed ID: 20225528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Condom use among injection drug users accessing a supervised injecting facility.
    Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
    Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
    Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture.
    Small W; Shoveller J; Moore D; Tyndall M; Wood E; Kerr T
    Qual Health Res; 2011 Jun; 21(6):743-56. PubMed ID: 21378259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada.
    Jozaghi E; Reid AA; Andresen MA; Juneau A
    Subst Abuse Treat Prev Policy; 2014 Aug; 9():31. PubMed ID: 25091704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canada's drug problem: time to get serious.
    Voth EA
    CMAJ; 1999 Feb; 160(4):477, 479. PubMed ID: 10081460
    [No Abstract]   [Full Text] [Related]  

  • 12. Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs.
    Jozaghi E; Jackson A
    Int J Health Policy Manag; 2015 Mar; 4(6):373-9. PubMed ID: 26029896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancouver's supervised injection facility challenges Canada's drug laws.
    Dooling K; Rachlis M
    CMAJ; 2010 Sep; 182(13):1440-4. PubMed ID: 20805208
    [No Abstract]   [Full Text] [Related]  

  • 14. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
    Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
    Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can HIV epidemics among injection drug users be prevented?
    Strathdee SA; van Ameijden EJ; Mesquita F; Wodak A; Rana S; Vlahov D
    AIDS; 1998; 12 Suppl A():S71-9. PubMed ID: 9632987
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.
    Hyshka E; Bubela T; Wild TC
    Addiction; 2013 Mar; 108(3):468-76. PubMed ID: 23286831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh?
    Foss AM; Watts CH; Vickerman P; Azim T; Guinness L; Ahmed M; Rodericks A; Jana S
    Addiction; 2007 Jan; 102(1):114-25. PubMed ID: 17207129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.
    Reddon H; Wood E; Tyndall M; Lai C; Hogg R; Montaner J; Kerr T
    AIDS Educ Prev; 2011 Oct; 23(5):412-22. PubMed ID: 22010805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent needle exchange use and HIV incidence in Vancouver, Canada.
    Wood E; Lloyd-Smith E; Li K; Strathdee SA; Small W; Tyndall MW; Montaner JS; Kerr T
    Am J Med; 2007 Feb; 120(2):172-9. PubMed ID: 17275459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of Vancouver's supervised injection facility.
    Bayoumi AM; Zaric GS
    CMAJ; 2008 Nov; 179(11):1143-51. PubMed ID: 19015565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.